From July 30 to August 4, 2023, tran Rui opened its 25th study tour (innovative medical theme) - Tokyo station, Japan, for 6 days and 5 nights. The theme of this inspection is innovative medical treatment. A group of more than 20 people, from all over the country and all walks of life, came to Tokyo with a sincere heart to learn Japanese innovative medical technology.

Every visit of chuangrei brings a little more surprise and progress. It is truly in line with international advanced medical technology, learning in practice and observation. On the way of chuangrei medical's study tour, there are wonderful things everywhere, which are worth learning and understanding about the medical industry. Participating in innovative medical activities has many benefits, which can not only improve their own medical technology and management ability, but also promote international cooperation, expand contacts and find business opportunities.

This article reviews the summary of medical institutions during the 25th Tokyo Station innovative medical investigation.

DONGBANG University Central Bridge Hospital

DONGBANG University central bridge hospital is an affiliated medical institution of DONGBANG University, with 6 affiliated medical institutions, including daemori hospital, Daqiao hospital, Sakura hospital, etc. In addition, there is an affiliated Sakura nursing college in Chiba county. There are international exchange programs with the University of Hawaii in the United States, the University of Alberta in Canada, Sichuan University in China, etc.

The delegation visited the bridge hospital of DONGBANG University Medical Center this time. His history can be traced back to 1964. In 2018, Daqiao hospital was transformed into a new general hospital and moved to the current new hospital site in the city center. Japan implements a hierarchical diagnosis and treatment system, and general hospitals work closely with regional clinics to provide efficient medical services for surrounding patients.

Visit to Abe Cancer Research Center

In Japan, 1million people get cancer every year, and one in three people dies of cancer. For cancer, the medical community has a variety of standard treatments, such as chemotherapy, radiotherapy, surgery, PD-1 drugs, etc., which have significantly improved the survival rate of cancer patients.

At the Tokyo cancer clinic, Dr. Nobuyuki Abe studied the immunotherapy of multi-stage dendritic cells combined with active NK cell therapy. According to the individual situation of each patient, Dr. Abe focuses on regenerative medicine and provides exact and effective treatment. In order to realize the health and longevity of the public, we should pay special attention to the medical treatment of "cancer", "disease prevention" and "anti-aging". These are closely related to each other and are necessary medical treatment for everyone.

Trustgarden senior nursing home

Three senior nursing homes in Tokyo under trustgarden, a resort trust group. These nursing homes have in common a comfortable environment, thoughtful service, and nursing and rehabilitation functions, but each has its own characteristics.

One of the nursing homes we visited was designed by Kengo Kuma, a Japanese national treasure designer. The whole is a Japanese courtyard style, with four floors above and below. The first floor is a restaurant, courtyard and rehabilitation area, and the second to third floors are older people's rooms. The rooms here are hotel style design, and set up elderly auxiliary facilities. Some areas of the nursing home on the fourth floor are planted with vegetables, which are green and healthy and integrate with the courtyard style.

Visit DCI partners

DCI partners is a professional venture capital fund focusing on the medical field under Daiwa Securities, Japan's second largest securities firm. Since the era of nif (predecessor of Daiwa Enterprise Investment Co., Ltd.) in 2014, it has accumulated more than 20 years of investment experience in the field of biotechnology. DCI operates the largest biotechnology and medical fund in Japan. Through the existing network with research institutions, biotechnology companies and pharmaceutical companies, and combined with professional knowledge such as drug development, intellectual property strategy and authorization strategy.

Visit Newton bio Capital Medical Investment Fund

Newton bio capital is a cross-border incubation and investment institution in Europe and Japan. Its founders are Alain parthoens and Goro Takeda. Invest in the field of life sciences, focus on chronic diseases, and focus on funding biotechnology and life science projects in Europe and Japan for the prevention and treatment of chronic diseases. The company's leadership team is composed of professionals with long-term management and investment experience, who provide guidance to biological entrepreneurs through the development phase of the project.

The 6-day and 5-night innovative medical journey is fleeting, and each day's journey is full of dry goods. Members of the delegation can intuitively contact Japan from zero distance. They have always been committed to innovative medical fields, aiming to improve the medical level and provide better services for patients. Pay attention to scientific and technological innovation and constantly introduce the latest medical equipment and technology to improve the medical diagnosis and treatment effect. The introduction of these devices and technologies has enabled Japan's medical industry to maintain a global leading position. Secondly, Japan emphasizes teamwork and interdisciplinary communication. Doctors, nurses, pharmacists and other professionals work closely together to develop the best treatment plan. In addition, medical institutions should establish close ties with universities and research institutions, strengthen the transformation and application of scientific research achievements, and promote medical progress.

In addition, Japan also attaches great importance to the experience and care of patients. They attach importance to doctor-patient communication, respect the opinions and needs of patients, and provide personalized medical services. At the same time, we should pay attention to medical quality management to ensure the safety and reliability of the medical process. In short, the purpose of innovative medical care in Japan is to improve the medical level, promote the development of medical science and technology, and provide better medical experience for patients. Through technological innovation, teamwork and patient care, Japan has continuously explored new paths in the medical field and made important contributions to the global medical cause.